Literature DB >> 6435514

Influence of inoculum size on comparative susceptibilities of penicillinase-positive and -negative Neisseria gonorrhoeae to 31 antimicrobial agents.

W H Hall, B J Opfer.   

Abstract

The effects of two inoculum sizes (10(4) and 10(6) CFU) on the MICs of 20 beta-lactam antibiotics, 4 aminoglycosides, and 7 other antimicrobial agents were compared for 102 unselected strains of Neisseria gonorrhoeae (26 penicillinase positive and 76 penicillinase negative), with three replicates for each test. The method was agar plate dilution on Mueller-Hinton agar supplemented with 1% hemoglobin and 1% IsoVitaleX. For penicillinase-positive strains, a large inoculum (10(6) CFU) increased the MIC greater than or equal to 16-fold for benzylpenicillin, piperacillin, azlocillin, and mezlocillin and increased the MIC greater than or equal to 8-fold for ampicillin, cefoperazone, ceftazidime, cefonicid, and cefamandole. The inoculum size had little or no influence on MICs of any antimicrobial agent for penicillinase-negative strains. For penicillinase-positive strains, the most active antibiotics (MIC, less than or equal to 0.001 microgram/ml) were the new cephalosporins: cefotaxime, ceftazidime, ceftizoxime, ceftriaxone, and cefmenoxime. For penicillinase-negative strains, the most active antibiotics were piperacillin, ceftriaxone, ceftizoxime, and cefmenoxime (MIC, less than or equal to 0.001 microgram/ml), closely followed by ceftazidime, moxalactam, azlocillin, mezlocillin, and cefuroxime.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435514      PMCID: PMC284117          DOI: 10.1128/AAC.26.2.192

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.

Authors:  J W Biddle; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

2.  In vitro antimicrobial activity of piperacillin and seven other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase producing strains.

Authors:  C Thornsberry; C N Baker; R N Jones
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

3.  Penicillinase-producing Gonococci in Liverpool.

Authors:  A Percival; J Rowlands; J E Corkill; C D Alergant; O P Arya; E Rees; E H Annels
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.

Authors:  C N Baker; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.

Authors:  W H Hall; B J Opfer; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

6.  Comparative susceptibility of penicillinase-positive and -negative Neisseria gonorrhoeae to 30 antibiotics.

Authors:  W H Hall; E A Schierl; J E Maccani
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

7.  Sensitivity of gonococci to rosoxacin compared with that of penicillin, cefuroxime and tetracycline.

Authors:  A D Seth
Journal:  J Antimicrob Chemother       Date:  1981-04       Impact factor: 5.790

8.  Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.

Authors:  A Thabaut; J L Durosoir; P Saliou
Journal:  Chemotherapy       Date:  1981       Impact factor: 2.544

9.  In vitro activity of Ro 13-9904, cefuroxime, cefoxitin, and ampicillin against Neisseria gonorrhoeae.

Authors:  T T Yoshikawa; S A Shibata; P Herbert; P A Oill
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

10.  Sulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae.

Authors:  M F Rein; W C Elliott; J M Swenson; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

View more
  6 in total

1.  In vitro activity of 14 antimicrobial agents against Neisseria gonorrhoeae from Spain.

Authors:  M C Lozano; J C Palomares; R Prados; E J Perea
Journal:  Genitourin Med       Date:  1987-06

Review 2.  Optimum therapy for acute pelvic inflammatory disease.

Authors:  M G Dodson
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

Review 3.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Effects of different media and methods of inoculum preparation on results of antimicrobial susceptibility testing of Neisseria gonorrhoeae by agar dilution.

Authors:  J A Dillon; W Tostowaryk; M Pauzé
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

5.  In vitro susceptibility of gram-positive cocci to paldimycin.

Authors:  D J Pohlod; L D Saravolatz; M M Somerville
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

6.  Cefuroxime axetil for treatment of uncomplicated gonorrhea.

Authors:  A Gottlieb; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.